Contraception in cancer survivors – an expert review Part II. Skin, gastrointestinal, haematological and endocrine cancers

Abstract

Objective: The efficacy of treatment for many cancers has increased dramatically in recent decades and there is a growing number of cancer survivors who need effective contraception. In this paper, a group of experts from the European Society of Contraception set out to define the most frequent cancers in women and summarise the guidelines, reviews and studies that provide information and guidance on contraception for each cancer.

Methods: Epidemiological studies were analysed to determine the frequency of cancers in women of reproductive age. A narrative review was performed for each cancer, collecting data about the treatment of the disease, its impact on fertility, and the efficacy, health risks, possible benefits and contraindications of the contraceptive methods available. The recommendations were then summarised.

Results: Owing to the large amount of information the results are presented in two parts. Part 1 includes contraception after breast and gynaecological cancers. Part 2 summarises the findings and recommendations regarding contraception in women with skin, gastrointestinal, haematological and endocrine cancers.

摘要

目的：近几十年来许多癌症的治疗效果显著提高, 越来越多的癌症生存者需要有效的避孕措施。在这篇文章中, 来自欧洲避孕学会的专家着手总结最常见女性肿瘤的指南、综述及研究, 以便为这些患者的避孕提供信息。

方法：流行病学研究分析来确定育龄期女性癌症的发生率。对每一种癌症进行回顾分析, 收集有关该疾病的治疗, 疗效, 对生育能力的影响, 健康风险, 避孕方法可能带来的益处以及禁忌证。

结果：由于信息量大, 研究结果分为两部分。第1部分包括乳腺癌和妇科癌症后的避孕措施。第2部分总结了皮肤癌, 胃肠肿瘤, 血液系统肿瘤及内分泌性肿瘤避孕措施的推荐及研究结果。

Keywords:

• Colorectal cancer
• contraception
• endocrine tumours
• hepatocellular carcinoma
• leukaemia
• lymphoma
• melanoma

Disclosure statement

No potential conflict of interest was reported by the authors.